Hillhouse Capital Management »

Bridgebio Pharma shares owned by Hillhouse Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Hillhouse Capital Management from 13F filings

Historical chart of Hillhouse Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Hillhouse Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Hillhouse Capital Management

Quarter filed Position value Share count Share price at filing
2019-06-30 $55M 2.0M 26.97

More positions owned by Hillhouse Capital Management

Iqiyi (IQ)
Uber Technologies (UBER)
Sea Ltd Adr Isin Us81141r1005 (SE)
Enstar Group (ESGR)
Beigene
Covetrus
Gossamer Bio (GOSS)
Nio Inc spon ads (NIO)
Alibaba Group Holding (BABA)
TAL Education (TAL)
Amazon (AMZN)
Facebook Inc cl a (META)
Bridgebio Pharma (BBIO)
Apellis Pharmaceuticals (APLS)
Pinduoduo (PDD)

View all positions for Hillhouse Capital Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
Aisling Capital Management
State Street Corporation
UBS Group
Henderson Group
Susquehanna International
Laurion Capital Management
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Alliancebernstein
Pictet Asset Management Holding SA

View all funds holding Bridgebio Pharma